HomeCompareBCHMF vs JNJ

BCHMF vs JNJ: Dividend Comparison 2026

BCHMF yields 0.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $89.00 in total portfolio value· pulled ahead in Year 10
10 years
BCHMF
BCHMF
● Live price
0.76%
Share price
$76.65
Annual div
$0.58
5Y div CAGR
-31.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$1.69
Full BCHMF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BCHMF vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCHMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCHMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCHMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCHMF
Annual income on $10K today (after 15% tax)
$64.32/yr
After 10yr DRIP, annual income (after tax)
$1.44/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $702.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCHMF + JNJ for your $10,000?

BCHMF: 50%JNJ: 50%
100% JNJ50/50100% BCHMF
Portfolio after 10yr
$20.0K
Annual income
$414.74/yr
Blended yield
2.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BCHMF
Analyst Ratings
1
Buy
1
Sell
Consensus: Buy
Altman Z
6.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCHMF buys
0
JNJ buys
0
No recent congressional trades found for BCHMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCHMFJNJ
Forward yield0.76%3.36%
Annual dividend / share$0.58$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-31.7%5.8%
Portfolio after 10y$19.9K$20.0K
Annual income after 10y$1.69$827.78
Total dividends collected$160.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BCHMF vs JNJ ($10,000, DRIP)

YearBCHMF PortfolioBCHMF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,752$51.68$10,676$355.77+$76.00BCHMF
2$11,540$35.47$11,407$389.39+$133.00BCHMF
3$12,372$24.30$12,198$426.53+$174.00BCHMF
4$13,255$16.63$13,056$467.62+$199.00BCHMF
5$14,194$11.37$13,987$513.12+$207.00BCHMF
6$15,195$7.77$14,998$563.56+$197.00BCHMF
7$16,264$5.31$16,098$619.52+$166.00BCHMF
8$17,406$3.63$17,295$681.69+$111.00BCHMF
9$18,627$2.48$18,599$750.82+$28.00BCHMF
10← crossover$19,933$1.69$20,022$827.78$89.00JNJ

BCHMF vs JNJ: Complete Analysis 2026

BCHMFStock

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland.

Full BCHMF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BCHMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCHMF vs SCHDBCHMF vs JEPIBCHMF vs OBCHMF vs KOBCHMF vs MAINBCHMF vs ABBVBCHMF vs MRKBCHMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.